source
- AstraZeneca proposes $10 billion purchase of Rhythm Pharmaceuticals, sparking possible bidding warAstraZeneca has reportedly made an offer of about $10 billion to buy Rhythm Pharmaceuticals, a company focused on rare obesity disorders. Analysts from at least three research groups say the propo…
- Agios to cut over 202 R&D positions as it awaits FDA decision on sickle cell drugAgios Pharmaceuticals said it will eliminate more than 100 research and development positions by the end of 2026, cutting its R&D workforce by roughly 35% from 2025 levels. The company entered the…